Evidence map›Paper›PMID 42738861›Full record

ArticleCells2026

New Biochemical Insights into RIT GTPases Regulation and Membrane Interactions.

Amin Mirzaiebadizi, Farhad Bazgir, Niloufar Mosaddeghzadeh, Silke Pudewell, Neda S Kazemein Jasemi, Radovan Dvorsky, Mohammad R Ahmadian

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amin MirzaiebadiziInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Building 22.03, 40225 Düsseldorf, Germany.ORCID 0000-0002-3340-586X
Farhad BazgirInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Building 22.03, 40225 Düsseldorf, Germany.ORCID 0000-0002-0689-7926
Niloufar MosaddeghzadehInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Building 22.03, 40225 Düsseldorf, Germany.ORCID 0000-0001-5786-8992
Silke PudewellInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Building 22.03, 40225 Düsseldorf, Germany.ORCID 0000-0002-4653-7263
Neda S Kazemein JasemiInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Building 22.03, 40225 Düsseldorf, Germany.ORCID 0000-0002-7842-6998
Radovan DvorskyInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Building 22.03, 40225 Düsseldorf, Germany.
Mohammad R AhmadianInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Building 22.03, 40225 Düsseldorf, Germany.ORCID 0000-0002-2034-8894

Funding

German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) AH 92/8-1
6 · The paper itself

Abstract

Both RIT1 and RIT2 are members of the RAS superfamily of small GTPases, which regulate various cellular processes. RIT1 is widely expressed, whereas RIT2 is primarily found in neuronal tissues. Dysregulation of these proteins has been associated with several human diseases, including Noonan syndrome, cancer, Parkinson's disease, autism, and schizophrenia. Although RIT1 and RIT2 are often compared to classical RAS proteins, they exhibit distinct regulatory and biochemical properties. Here, we demonstrate that RIT1 differs from classical RAS in GTPase cycling. Unlike classical RAS proteins, RIT1 did not respond to SOS1-mediated nucleotide exchange or p120GAP-stimulated GTP hydrolysis under cell-free conditions. These results imply that RIT1 may depend on regulatory mechanisms that differ from those of classical RAS proteins. However, the relevant physiological regulators remain unknown. Disease-associated RIT1 mutations cluster around the P-loop and Switch II regions. In this transient overexpression screening system, however, these mutations had only a modest effect on the canonical MAPK, PI3K/AKT, and JNK signaling pathways in HEK293T overexpression experiments. This suggests the existence of additional context-specific effectors and regulatory factors. We demonstrate that RIT1 and RIT2 interact with membrane lipids via a basic C-terminal extension. The KRLK-containing region contributes to the binding of phosphatidylserine and phosphoinositides. Charge-reversal mutations disrupt lipid interactions and liposome binding, supporting the functional importance of this region. In a reconstituted liposome system, galectin-3 and LZTR1, but not galectin-1, reduced the interaction of GDP-loaded RIT1 and RIT2 with liposomes. These results suggest that accessory proteins may influence RIT membrane interactions. However, their cellular relevance requires further validation. Together, our findings provide biochemical insights into RIT GTPase regulation and its interactions with membrane lipids under cell-free conditions.

Indexed as

Cell Membraneras ProteinsHEK293 CellsHumansMembrane LipidsMonomeric GTP-Binding ProteinsMutationProtein BindingSignal TransductionSOS1 ProteinMembrane LipidsMonomeric GTP-Binding Proteinsras ProteinsRIT1 protein, humanSOS1 ProteinGalectin-3lipid interactionsLZTR1phosphoinositide bindingRASopathiesRAS superfamilyRIT1RIT2small GTPases

Identifiers

PMID42738861
PMCPMC13565119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.